Clinical information for the Ugandan and Ghanaian BL patient cohorts
| Characteristic . | Ugandan cohort(n = 19) . | Ghanaian cohort(n = 29*) . |
|---|---|---|
| Sex, no. (%) | ||
| Female | 7 (37) | 13 (45) |
| Male | 12 (63) | 16 (55) |
| Age at enrollment, y | ||
| Median | 7 | 9 |
| Range | 4-12 | 4-13 |
| HIV status, no. (%) | ||
| Negative | 18 (95) | 29 (100) |
| Positive | 1 (5) | 0 (0) |
| Ziegler disease stage, no. (%)† | ||
| A | 7 (37) | 2 (10) |
| B | 3 (16) | 0 (0) |
| C | 3 (16) | 15 (75) |
| D | 6 (31) | 3 (15) |
| Characteristic . | Ugandan cohort(n = 19) . | Ghanaian cohort(n = 29*) . |
|---|---|---|
| Sex, no. (%) | ||
| Female | 7 (37) | 13 (45) |
| Male | 12 (63) | 16 (55) |
| Age at enrollment, y | ||
| Median | 7 | 9 |
| Range | 4-12 | 4-13 |
| HIV status, no. (%) | ||
| Negative | 18 (95) | 29 (100) |
| Positive | 1 (5) | 0 (0) |
| Ziegler disease stage, no. (%)† | ||
| A | 7 (37) | 2 (10) |
| B | 3 (16) | 0 (0) |
| C | 3 (16) | 15 (75) |
| D | 6 (31) | 3 (15) |